- Article
Targeted Removal of HCV E2 N2 N-Glycan Is Associated with Improved Immune Responses in Mice
- Yuan-Qin Min,
- Yu-Shan Ren,
- Wen-Wen Zhang,
- Yi-Dan Zhou and
- Min Liu
24 January 2026
Hepatitis C virus (HCV) still lacks a licensed vaccine. The envelope glycoprotein E2 is a key neutralizing target, but its dense N-glycan shield can hinder epitope exposure. In this study, we revisit E2 glycan editing and examine whether single-site...

